XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 9,377 $ 22,245
Inventory 0 3,024
Prepaid expense and other current assets 32,890 51,144
Total current assets 42,267 76,413
Patents, net 177,051 180,628
Property and equipment, net 2,921 3,249
Total assets 222,239 260,290
Liabilities and Stockholders' Equity (Deficit)    
Accounts payable and accrued expenses 348,548 145,567
Notes payable - related party 236,854 0
Convertible notes payable – related party 915,016 953,001
Total current liabilities 1,500,418 1,098,568
Total liabilities 1,500,418 1,098,568
Stockholders' equity (deficit)    
Preferred stock, $0.01 par value: Authorized shares - 10,000,000, Issued and outstanding shares – 0 at March 31, 2021 and December 31, 2020 0 0
Common stock, $0.01 par value: Authorized shares - 100,000,000, Issued and outstanding shares – 42,066,172 and 42,066,172 at March 31, 2021 and December 31, 2020, respectively 420,662 420,662
Additional paid-in capital 5,055,420 4,961,315
Accumulated deficit (6,754,261) (6,220,255)
Total stockholders’ equity (deficit) (1,278,179) (838,278)
Total liabilities and stockholders’ equity (deficit) $ 222,239 $ 260,290